Sign in

CIK 0001228627

  • Non-accelerated filer
  • Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
113516358
Phone
+1 984-884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 5 Insider Annual Insider Trading Report
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Director acquired 4,021 shares (grant or award)
  6. 4 Grant or award Director acquired 2,949 shares (grant or award)
  7. 4 Open-market buy Director bought 8,250 shares at $3.65 ($30,113)
  8. 4 Open-market buy Director bought 2,000 shares at $3.50 ($7,000)
  9. 4 Grant or award Director acquired 2,135 shares (grant or award)
  10. 4 Grant or award Director acquired 2,912 shares (grant or award)
  11. 4 Open-market buy Director bought 12,631 shares at $4.75 ($59,997)
  12. 4 Open-market buy Director bought 20,000 shares at $4.57 ($91,400)
  13. 4 Grant or award Director acquired 2,083 shares (grant or award)
  14. 4 Grant or award Director acquired 2,840 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 21 · 403 filings